Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Passage Bio Inc.

    NASDAQ: PASG · Real-Time Price · USD
    0.46
    0.04 (8.80%)
    At close: Jun 09, 2025, 3:59 PM

    Passage Bio Statistics

    Share Statistics

    Passage Bio has 62.15M shares outstanding. The number of shares has increased by 0.82% in one year.

    Shares Outstanding

    n/a
    		 62.15M

    Shares Change (YoY)

    n/a
    		 0.82%

    Shares Change (QoQ)

    n/a
    		 0.62%

    Owned by Institutions (%)

    n/a
    		 60.93%

    Shares Floating

    n/a
    		 52.62M

    Failed to Deliver (FTD) Shares

    n/a
    		 4,880

    FTD / Avg. Volume

    n/a
    		 1.94%

    Short Selling Information

    The latest short interest is 1.74M, so 2.79% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.74M

    Short % of Shares Out

    n/a
    		 2.79%

    Short % of Float

    n/a
    		 3.8%

    Short Ratio (days to cover)

    n/a
    		 6.1

    Valuation Ratios

    The PE ratio is -0.53 and the forward PE ratio is -0.62. Passage Bio's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.53

    Forward PE

    n/a
    		 -0.62

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0.56

    P/FCF Ratio

    n/a
    		 -0.71

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Passage Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 4.07, with a Debt / Equity ratio of 0.42.

    Current Ratio

    n/a
    		 4.07

    Quick Ratio

    n/a
    		 4.07

    Debt / Equity

    n/a
    		 0.42

    Debt / EBITDA

    n/a
    		 -0.41

    Debt / FCF

    n/a
    		 -0.53

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,079,450

    Employee Count

    n/a
    		 60

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -64.71% in the last 52 weeks. The beta is 1.7, so Passage Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.7

    52-Week Price Change

    n/a
    		 -64.71%

    50-Day Moving Average

    n/a
    		 0.36

    200-Day Moving Average

    n/a
    		 0.56

    Relative Strength Index (RSI)

    n/a
    		 55.86

    Average Volume (20 Days)

    n/a
    		 251,284

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -70.4M

    Net Income

    n/a
    		 -64.77M

    EBITDA

    n/a
    		 -61.69M

    EBIT

    n/a
    		 -64.77M

    Earnings Per Share (EPS)

    n/a
    		 -1.07
    Full Income Statement

    Balance Sheet

    The company has 37.57M in cash and 25.48M in debt, giving a net cash position of 12.1M.

    Cash & Cash Equivalents

    n/a
    		 37.57M

    Total Debt

    n/a
    		 25.48M

    Net Cash

    n/a
    		 12.1M

    Retained Earnings

    n/a
    		 -659.24M

    Total Assets

    n/a
    		 86.01M

    Working Capital

    n/a
    		 48.84M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -47.96M and capital expenditures -34K, giving a free cash flow of -47.99M.

    Operating Cash Flow

    n/a
    		 -47.96M

    Capital Expenditures

    n/a
    		 -34K

    Free Cash Flow

    n/a
    		 -47.99M

    FCF Per Share

    n/a
    		 -0.79
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PASG does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PASG is $6, which is 1328.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 1328.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -12.31

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist